⌘K

Login Start Free

Home/Filings/4/0001062993-24-009329

4//SEC Filing

Doyle John Brendan 4

Accession 0001062993-24-009329

CIK 0001455365other

View on SEC.gov Company Profile

Filed

May 2, 8:00 PM ET

Accepted

May 3, 4:07 PM ET

Size

4.8 KB

Accession

0001062993-24-009329

Insider Transaction Report

Form 4

Period: 2024-05-01

COGNITION THERAPEUTICS INCCGTX

Doyle John Brendan

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2024-05-01$1.95/sh−8,699$16,963→ 121,125 total

Footnotes (1)

[F1]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

COGNITION THERAPEUTICS INC

CIK 0001455365

Entity typeother

Related Parties

1

filerCIK 0001840738

Filing Metadata

Form type: 4
Filed: May 2, 8:00 PM ET
Accepted: May 3, 4:07 PM ET
Size: 4.8 KB

View on SEC.gov